Medicare IVIG Access Enhancement Act
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Dec 21, 2017)
Medicare IVIG Access Enhancement Act
This bill requires the Centers for Medicare & Medicaid Services to establish a three-year demonstration project to evaluate the benefits of providing Medicare coverage and payment for items and services needed for the in-home administration of intravenous immune globulin to treat chronic inflammatory demyelinating polyneuropathy or multifocal motor neuropathy. Beneficiary participation shall be voluntary.
What just happenedDec 22, 2017
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseDec 21, 2017
- Dec 22, 2017Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Dec 21, 2017IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Ways and Means Committee - Dec 21, 2017IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Energy and Commerce Committee - Dec 21, 2017IntroReferralIntro-H
Introduced in House
- Dec 21, 2017IntroReferral1000
Introduced in House